tiprankstipranks
Hemogenyx Pharmaceuticals Announces Total Share Capital
Company Announcements

Hemogenyx Pharmaceuticals Announces Total Share Capital

Story Highlights

Invest with Confidence:

An announcement from HemoGenyx Pharmaceuticals Plc ( (GB:HEMO) ) is now available.

Hemogenyx Pharmaceuticals plc has announced its total issued share capital as of January 31, 2025, which consists of 3,604,539 ordinary shares. This figure is important for shareholders as it is used to calculate their investment interests under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

More about HemoGenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals plc is a biopharmaceutical company focused on developing new therapies and treatments for blood diseases.

YTD Price Performance: -10.0%

Average Trading Volume: 26,901

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £13.14M

See more data about HEMO stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App